loading

Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie

pulisher
10:39 AM

Wells Fargo & Company Issues Positive Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price - MarketBeat

10:39 AM
pulisher
10:27 AM

Cantor Fitzgerald Boosts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $740.00 - MarketBeat

10:27 AM
pulisher
10:17 AM

Regeneron (REGN) Margin Compression Reinforces Cautious Community Narratives Heading Into Earnings Season - Yahoo Finance

10:17 AM
pulisher
09:29 AM

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $865.00 at Guggenheim - MarketBeat

09:29 AM
pulisher
08:22 AM

Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, Bank of America Analyst Says - MarketBeat

08:22 AM
pulisher
08:05 AM

Can Regeneron Pharmaceuticals Inc. stock maintain operating marginsTrade Exit Report & Verified Swing Trading Watchlists - newser.com

08:05 AM
pulisher
08:05 AM

Why Regeneron Pharmaceuticals Inc. stock is considered a top pickCPI Data & Daily Oversold Bounce Ideas - newser.com

08:05 AM
pulisher
08:00 AM

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewswire Inc.

08:00 AM
pulisher
07:45 AM

Regeneron (REGN) Margin Dip Underscores Market Caution Despite Strong Relative Valuation - simplywall.st

07:45 AM
pulisher
06:30 AM

Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by Evergreen Wealth Management LLC - MarketBeat

06:30 AM
pulisher
05:02 AM

Why Regeneron Pharmaceuticals Inc. (RGO) stock is listed among top recommendations - newser.com

05:02 AM
pulisher
04:33 AM

Using fundamentals and technicals on Regeneron Pharmaceuticals Inc.Profit Target & Risk Controlled Stock Alerts - newser.com

04:33 AM
pulisher
04:30 AM

Wealthfront Advisers LLC Sells 1,560 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

04:30 AM
pulisher
04:13 AM

Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by AlphaQuest LLC - MarketBeat

04:13 AM
pulisher
03:51 AM

Why millennials buy Regeneron Pharmaceuticals Inc. (RGO) stockJuly 2025 PostEarnings & AI Driven Stock Price Forecasts - newser.com

03:51 AM
pulisher
02:25 AM

Why Regeneron Pharmaceuticals Inc. (RGO) stock is a strong buy callWeekly Trade Report & Free Safe Capital Growth Stock Tips - newser.com

02:25 AM
pulisher
02:21 AM

News impact scoring models applied to Regeneron Pharmaceuticals Inc.Fed Meeting & Daily Oversold Bounce Ideas - newser.com

02:21 AM
pulisher
Oct 29, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to Issue $0.88 Quarterly Dividend - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

In a $1B+ deal, Modex joins with Regeneron to develop antibodies - BioWorld MedTech

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron receives another CRL for its Eylea 8 mg - Ophthalmology Times

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron's Portfolio Still Supports a Narrow Moat Despite Competitive Threats to Eylea - Morningstar

Oct 29, 2025
pulisher
Oct 29, 2025

REGN Receives Analyst Rating Boost with New Price Target | REGN Stock News - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron Pharmaceuticals (REGN) Sees Revised Price Target by RB - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron Q3 Earnings Review: This Is The Start Of A Dupixent Driven Comeback (REGN) - Seeking Alpha

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron’s Aflibercept Study Sheds Light on Retinal Vasculitis Incidence - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron Adds Fuel to Hot Healthcare Trade. Which Stocks Could Follow it Higher? - Barron's

Oct 29, 2025
pulisher
Oct 29, 2025

Market Starting To Embrace The 'New' Regeneron (NASDAQ:REGN) - Seeking Alpha

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron pledges more than $1B biobucks for ModeX multispecific antibodies - Fierce Biotech

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron Pharmaceuticals (NASDAQ:REGN) Shares Gap Up Following Earnings Beat - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Wells Fargo Raises Regeneron (REGN) Price Target Amidst Equal-We - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron teams up with Gary Nabel’s ModeX on multispecifics - Endpoints News

Oct 29, 2025
pulisher
Oct 29, 2025

Cantor Fitzgerald Boosts Price Target for Regeneron Pharmaceuticals (REGN) | REGN Stock News - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron Pharmaceuticals (NASDAQ:REGN) Announces Earnings Results, Beats Estimates By $2.10 EPS - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Guggenheim Raises Regeneron Pharmaceuticals (REGN) Price Target to $865 | REGN Stock News - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron Partners With ModeX Therapeutics To Discover And Develop Multispecific Antibodies - Nasdaq

Oct 29, 2025
pulisher
Oct 29, 2025

FDA Formally Rejects Regeneron’s Eylea HD Over Manufacturing Issues - BioSpace

Oct 29, 2025
pulisher
Oct 29, 2025

FDA rejects Regeneron’s pre-filled Eylea HD syringes amid filling facility woes - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron Pharmaceuticals (REGN) Analyst Rating Update: Price Ta - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

RBC Raises Price Target on Regeneron Pharmaceuticals to $708 From $704, Keeps Sector Perform Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Opko Health’s ModeX enters license, collab agreement with Regeneron - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

FDA rejects Regeneron’s Eylea HD amid filling facility woes - Pharmaceutical Technology

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2025 Earnings Call Transcript - Insider Monkey

Oct 29, 2025
pulisher
Oct 29, 2025

OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

What data driven models say about Regeneron Pharmaceuticals Inc.’s futureJuly 2025 Rallies & Real-Time Volume Analysis - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Morgan Stanley Adjusts Price Target on Regeneron Pharmaceuticals to $767 From $756, Maintains Overweight Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

BMO Capital Adjusts Price Target on Regeneron Pharmaceuticals to $725 From $640, Maintains Outperform Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Evaluating Regeneron After Recent Pipeline News and Sharp 13% Stock Surge - simplywall.st

Oct 29, 2025
pulisher
Oct 29, 2025

Citigroup Adjusts Price Target on Regeneron Pharmaceuticals to $700 From $660, Maintains Buy Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Baird Adjusts Price Target on Regeneron Pharmaceuticals to $630 From $587, Maintains Neutral Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

General American Investors Co. Inc. Sells 5,000 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

TD Cowen Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $780, Maintains Buy Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Goldman Sachs Adjusts Price Target on Regeneron Pharmaceuticals to $788 From $785, Maintains Buy Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Leerink Partners Adjusts Price Target on Regeneron Pharmaceuticals to $710 From $645, Maintains Outperform Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Raymond James Adjusts Price Target on Regeneron Pharmaceuticals to $723 From $673, Maintains Outperform Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $740 From $658, Maintains Overweight Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

JPMorgan Adjusts Price Target on Regeneron Pharmaceuticals to $850 From $800, Maintains Overweight Rating - MarketScreener

Oct 29, 2025
pulisher
Oct 29, 2025

Novartis’ Big Buy, Q3 Earnings, Regeneron’s Dropped Cell Therapy, More - BioSpace

Oct 29, 2025
pulisher
Oct 29, 2025

Heatmap analysis for Regeneron Pharmaceuticals Inc. and competitorsBull Run & Stock Timing and Entry Methods - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Teacher Retirement System of Texas Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

OVERSEA CHINESE BANKING Corp Ltd Cuts Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron Pharmaceuticals Faces Financial Risks Amid Tariff and Trade Challenges - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight - GuruFocus

Oct 29, 2025
pulisher
Oct 29, 2025

Regeneron Pharmaceuticals Reports Q3 2025 Financial Results - TipRanks

Oct 29, 2025
pulisher
Oct 28, 2025

Regeneron Earnings Call: Strong Growth Amid Challenges - TipRanks

Oct 28, 2025
pulisher
Oct 28, 2025

Regeneron's Earnings Took A Big Tax Hit, And Still Pounded Forecasts - Investor's Business Daily

Oct 28, 2025
pulisher
Oct 28, 2025

Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Oct 28, 2025
pulisher
Oct 28, 2025

Regeneron (REGN) Q3 2025 Earnings Call Transcript - The Motley Fool

Oct 28, 2025
pulisher
Oct 28, 2025

Big Names In Health Care Diverge As Market Stumbles - Finimize

Oct 28, 2025
pulisher
Oct 28, 2025

Tranche Update on Regeneron Pharmaceuticals, Inc.'s Equity Buyback Plan announced on February 4, 2025. - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

JPMorgan Raises Price Target on Regeneron Pharmaceuticals to $850 From $800 - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Pharma Boom: Regeneron’s Latest Innovations - StocksToTrade

Oct 28, 2025
pulisher
Oct 28, 2025

REGN Stock Up on Q3 Earnings Beat, Eylea HD Sales Increase - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

FDA rebuff puts new dent in Regeneron's bid to crank up Eylea HD rollout - FirstWord Pharma

Oct 28, 2025
$443.65
price down icon 7.59%
$805.54
price down icon 1.80%
$188.72
price up icon 13.13%
biotechnology ONC
$310.09
price down icon 1.58%
$420.70
price up icon 0.79%
Capitalizzazione:     |  Volume (24 ore):